Small clinical studies in the pediatric population have attempted to investigate the role of hepcidin as a biomarker for the diagnosis of bacterial infections, but the requested cutoff value has not yet been identified [23,26,27,28]. This evidence concerns the gene HAMP and bacterial infectious disease.